{"filing":{"accession_number":"0000816956-26-000101","cik":"0000816956","ticker":"CNMD","company_name":"CONMED Corp","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"cnmd-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000101/cnmd-20260729.htm"},"events":[{"id":21636,"run_id":19517,"accession_number":"0000816956-26-000101","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"CONMED Corporation issued a press release on July 29, 2026 announcing second quarter 2026 financial results for the period ended June 30, 2026, including net sales of $343.5 million, diluted EPS of $0.77 (GAAP) and $1.38 (adjusted), along with updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21325,"accession_number":"0000816956-26-000101","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"CONMED Corporation issued a press release on July 29, 2026 announcing second quarter 2026 financial results for the period ended June 30, 2026, including net sales of $343.5 million, diluted EPS of $0.77 (GAAP) and $1.38 (adjusted), along with updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:16:28.669858+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21325,"accession_number":"0000816956-26-000101","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"CONMED Corporation issued a press release on July 29, 2026 announcing second quarter 2026 financial results for the period ended June 30, 2026, including net sales of $343.5 million, diluted EPS of $0.77 (GAAP) and $1.38 (adjusted), along with updated full-year 2026 guidance. The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:16:28.669858+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-07-29"}]}